C4 Therapeutics's market cap is currently $211.06M. The company's EPS TTM is $-1.704; its P/E ratio is ―; C4 Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 20.76M	$ 31.10M	$ 45.78M	$ 33.20M	$ 21.38M
Gross Profit	$ -96.95M	$ 23.52M	$ 42.88M	$ -44.27M	$ -26.28M
Operating Income	$ -139.03M	$ -129.53M	$ -82.13M	$ -60.45M	$ -35.45M
EBITDA	$ -122.10M	$ -124.28M	$ -78.84M	$ -62.89M	$ -30.56M
Net Income	$ -132.49M	$ -126.50M	$ -86.04M	$ -66.33M	$ -34.10M
Balance Sheet
Cash & Short-Term Investments	$ 253.68M	$ 337.12M	$ 309.28M	$ 371.69M	$ 90.55M
Total Assets	$ 376.45M	$ 430.84M	$ 506.76M	$ 400.14M	$ 118.26M
Total Debt	$ 70.98M	$ 87.15M	$ 42.88M	$ 22.92M	$ 13.75M
Net Debt	$ -55.61M	$ 57.40M	$ -33.24M	$ -158.81M	$ -76.80M
Total Liabilities	$ 130.34M	$ 141.61M	$ 117.16M	$ 119.35M	$ 230.22M
Stockholders' Equity	$ 246.11M	$ 289.23M	$ 389.61M	$ 280.79M	$ -111.96M
Cash Flow
Free Cash Flow	$ -108.55M	$ -111.44M	$ -88.24M	$ -67.90M	$ 54.27M
Operating Cash Flow	$ -106.84M	$ -105.94M	$ -86.97M	$ -67.25M	$ 55.61M
Investing Cash Flow	$ 158.35M	$ 58.42M	$ -189.34M	$ -190.50M	$ -1.62M
Financing Cash Flow	$ 45.49M	$ 1.15M	$ 171.40M	$ 348.93M	$ 244.00K

Currency in USD

C4 Therapeutics Earnings and Revenue History

Income Statement >

C4 Therapeutics Debt to Assets

Balance Sheet >

C4 Therapeutics Cash Flow

Cash Flow >

C4 Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing